Allergan to sell multibillion-dollar women’s health and infectious disease units after strategic review

Allergan to sell multibillion-dollar women’s health and infectious disease units after strategic review

Allergan has completed its strategic review and will sell its women’s health and infectious disease businesses, sources told CNBC. The drugmaker announced the review earlier this year, but Brent Saunders, its chief executive, has said he was opposed to fundamental changes to its business strategy. Still, the review considered options such as splitting up the company, selling assets, making acquisitions and using capital to buy back shares. Saunders is scheduled to make a presentation at…

Read More